Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MiLaboratories
AddedFeb 16, 2024
UpdatedJun 18, 2026
MiLaboratories

MiLaboratories

MiXCR: Leading NGS data analysis software for immune profiling, empowering R&D in vaccine development & more.

HQ
Sunnyvale, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

MiLaboratories, founded with a mission to advance computational biology, focuses on providing cutting-edge software solutions for the analysis of Next-Generation Sequencing (NGS) data. Their flagship product, MiXCR, is a leading platform for immune profiling, widely utilized in vaccine development, CAR-T therapies, and antibody discovery. MiLaboratories serves a diverse market that includes both academic institutions and the pharmaceutical industry, offering MiXCR for free to non-profit researchers to support scientific advancement.

Notable affiliations include partnerships with 8 out of the top 10 Big Pharma companies, underscoring the platform's industry trust and reliability. Key achievements include MiXCR's recognition as the premier solution for immune system studies in both academia and industry. The impact of MiLaboratories is significant, driving forward research and development in critical areas of healthcare and immunology, thereby contributing to the broader scientific community's efforts in combating diseases.

MiLaboratories - Similar Companies

Insightful Science logo

Insightful Science

Maverix Biomics logo

Maverix Biomics

maverixbio.com

Biomiic logo

Biomiic

BioTuring logo

BioTuring

bioturing.com

LatchBio logo

LatchBio

latch.bio

Omix.ai logo

Omix.ai

Analytica Biosciences logo

Analytica Biosciences

MitoLab logo

MitoLab

Bioinformatics logo

Bioinformatics

bioinfoinc.com

BioDatomics logo

BioDatomics

biodatomics.com

Basepair logo

Basepair

basepairtech.com

Thermo Fisher th logo

Thermo Fisher th

thermofisher.com

MetaCell logo

MetaCell

metacell.us

Nexilico logo

Nexilico

nexilico.com

OmicsCraft logo

OmicsCraft

omicscraft.com

MiLaboratories - Quick Facts

Who are MiLaboratories' competitors?

Companies similar to MiLaboratories include Insightful Science, Maverix Biomics, Biomiic and BioTuring.

When was MiLaboratories founded?

MiLaboratories was founded in 2021.

Where is MiLaboratories' headquarters located?

MiLaboratories' headquarters is located in Sunnyvale, CA, US.

When was MiLaboratories' last funding round?

MiLaboratories' most recent funding round was for $2.4M (USD) in February 2022.

How much has MiLaboratories raised to-date?

As of Feb 17, 2022, MiLaboratories has raised a total of $2.4M (USD).

How many employees does MiLaboratories have?

MiLaboratories has 14 employees as of Feb 5, 2024.

MiLaboratories - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • NGS Data Analysis
Tags
  • Biotech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software